Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Assets (2016 - 2025)

Historic Return on Assets for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to 0.02%.

  • Amicus Therapeutics' Return on Assets rose 1200.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.07% for FY2024, which is 1300.0% up from last year.
  • Latest data reveals that Amicus Therapeutics reported Return on Assets of 0.02% as of Q3 2025, which was up 1200.0% from 0.05% recorded in Q2 2025.
  • Over the past 5 years, Amicus Therapeutics' Return on Assets peaked at 0.02% during Q3 2025, and registered a low of 0.35% during Q2 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.26% (2023), whereas its average is 0.22%.
  • Per our database at Business Quant, Amicus Therapeutics' Return on Assets plummeted by -600bps in 2022 and then skyrocketed by 1600bps in 2025.
  • Amicus Therapeutics' Return on Assets (Quarter) stood at 0.27% in 2021, then decreased by -19bps to 0.32% in 2022, then skyrocketed by 38bps to 0.2% in 2023, then skyrocketed by 64bps to 0.07% in 2024, then skyrocketed by 77bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.05% for Q2 2025, and 0.04% during Q1 2025.